As Managing Director of the Company, Mr. Rakesh oversees all operations of the organization. During his tenure, he transformed DRT into a truly global organization and commercial presence in over 11 countries. Under his leadership, DRT has evolved from an Indian branded generics business, into aExport House organization. Mr. Rakesh vision is to discover, develop and deliver innovative quality medicines that help patients prevail over different diseases.
Mr. Rakesh holds a very good experience of pharmaceutical manufacturing & marketing is an MBA from a Business School. Prior to DRT, he was associated with few leading pharmaceutical companies in India on top positions.
All business activities at DRT stand firmly on the foundation of our commitment to ethics, integrity and compliance with all applicable laws, regulations, guidelines and industry codes.
DRT is also dedicated to the highest standards of ethical behaviour and to economic, social and environmental sustainability. The Standards of Business Conduct and Ethics for Third Parties (3P Standards) apply to all third-party companies with whom DRT has agreements, such as suppliers, distributors, consultants, agents, service providers, joint ventures, co-promotion and research or licensing partners (Third Parties).
DRT recognizes that Third Parties have an important role in DRT’s success and DRT strives to conduct business only with Third Parties who share its commitment to the 3P Standards. Therefore, DRT’s Third Parties are expected to have processes and/or systems in place to support operating in compliance with all applicable laws, regulations, guidelines and industry codes.
